Citation: | Guangbo Fu, Jialin Tang, Meilin Wang, Chao Qin, Fu Yan, Qi Ding, Changjun Yin, Xinru Wang, Zhengdong Zhang. CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men[J]. The Journal of Biomedical Research, 2011, 25(2): 128-134. DOI: 10.1016/S1674-8301(11)60016-X |
[1] | Yifei Cheng, Rongjie Shi, Shuai Ben, Silu Chen, Shuwei Li, Junyi Xin, Meilin Wang, Gong Cheng. Genetic variation of circHIBADH enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing[J]. The Journal of Biomedical Research, 2024, 38(4): 358-368. DOI: 10.7555/JBR.38.20240030 |
[2] | Lulu Fan, Hao Wang, Shuai Ben, Yifei Cheng, Silu Chen, Zhutao Ding, Lingyan Zhao, Shuwei Li, Meilin Wang, Gong Cheng. Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated FAM227A expression[J]. The Journal of Biomedical Research, 2024, 38(2): 149-162. DOI: 10.7555/JBR.37.20230049 |
[3] | Li Xin, Yang Jian, Chen Xia, Cao Dandan, Xu Eugene Yujun. PUM1 represses CDKN1B translation and contributes to prostate cancer progression[J]. The Journal of Biomedical Research, 2021, 35(5): 371-382. DOI: 10.7555/JBR.35.20210067 |
[4] | Du Haina, Song Guoxin, Fang Mingzhi, Shu Yongqian, Zhao Xin, Zhu Lingjun. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk[J]. The Journal of Biomedical Research, 2019, 33(3): 173-180. DOI: 10.7555/JBR.32.20160030 |
[5] | Il-Seok Lee, Sung Pil Seo, Yun Sok Ha, Pildu Jeong, Ho Won Kang, Won Tae Kim, YongJune Kim, Seok Joong Yun, Sang Cheol Lee, Wun-Jae Kim. Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer[J]. The Journal of Biomedical Research, 2017, 31(3): 226-231. DOI: 10.7555/JBR.31.20160072 |
[6] | Marwan Ghosn, Alain Dagher, Fadi El-Karak. Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient[J]. The Journal of Biomedical Research, 2015, 29(5): 420-422. DOI: 10.7555/JBR.28.20130148 |
[7] | William Weiben Zhang, Zhenqing Feng, Steven A Narod. Multiple therapeutic and preventive effects of 3,39-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia[J]. The Journal of Biomedical Research, 2014, 28(5): 339-348. DOI: 10.7555/JBR.28.20140008 |
[8] | Lifeng Zhang, Ning Shao, Qianqian Yu, Lixin Hua, Yuanyuan Mi, Ninghan Feng. Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis[J]. The Journal of Biomedical Research, 2011, 25(1): 25-32. DOI: 10.1016/S1674-8301(11)60003-1 |
[9] | Yuanyuan Mi, Qianqian Yu, Zhichao Min, Bin Xu, Lifeng Zhang, Wei Zhang, Ninghan Feng, Lixin Hua. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis[J]. The Journal of Biomedical Research, 2010, 24(5): 365-373. DOI: 10.1016/S1674-8301(10)60049-8 |
[10] | Bingbing Wei, Yunyun Zhang, Bo Xi, Junkai Chang, Jinming Bai, Jiantang Su. CYP17 T27C polymorphism and prostate cancer risk:a meta-analysis based on 31 studies[J]. The Journal of Biomedical Research, 2010, 24(3): 233-241. |